Isoniazid 100 MG Oral Tablet — RxCUI 311166
RxNorm drug concept · Semantic clinical drug
RxCUI 311166
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311166
Official nameIsoniazid 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asINH 100 MG Oral Tablet
FDA products mapped11
Package NDCs mapped16
Reported Medicaid activity (SDUD)29,156 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Isoniazid: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- TB bacteria are clever — they can develop resistance to a single drug very quickly, which would make your infection much harder to treat. Using isoniazid together with other anti-T...
- Why do I have to take isoniazid with other TB medications? Can't I just take this one?
- Liver damage is the most serious risk with isoniazid, and it's important to take it seriously — but your doctor will be monitoring you for this. You'll have monthly check-ins, and...
- I heard isoniazid can hurt my liver. How worried should I be?
🕸️ Concept Web — How Isoniazid 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Isoniazid 100 MG Oral Tablet
RxCUI 311166 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Isoniazid
6038IN
-
Isoniazid
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Isoniazid Oral Tablet
370716SCDF -
Isoniazid Oral Product
1161935SCDG -
Isoniazid Pill
1161936SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Isoniazid Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Isoniazid 100 MG
316105SCDC
-
Isoniazid 100 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Isoniazid 100 MG
SCDC · 316105 -
Isoniazid Oral Tablet
SCDF · 370716 -
Isoniazid Oral Product
SCDG · 1161935 -
Isoniazid Pill
SCDG · 1161936
📦 FDA Products & Package NDCs
11 products · 16 package NDCs
16 package NDCs map to RxCUI 311166 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00555-0066-02 | 100 TABLET in 1 BOTTLE (0555-0066-02) | Isoniazid | Teva Pharmaceuticals USA, Inc. | 1972-09-01 |
| 00555-0071-01 | 30 TABLET in 1 BOTTLE, UNIT-DOSE (0555-0071-01) | Isoniazid | Teva Pharmaceuticals USA, Inc. | 1972-09-01 |
| 00555-0071-02 | 100 TABLET in 1 BOTTLE (0555-0071-02) | Isoniazid | Teva Pharmaceuticals USA, Inc. | 1972-09-01 |
| 10135-0804-01 | 100 TABLET in 1 BOTTLE, PLASTIC (10135-804-01) | isoniazid | Marlex Pharmaceuticals, Inc. | 2025-03-01 |
| 10135-0805-01 | 100 TABLET in 1 BOTTLE, PLASTIC (10135-805-01) | isoniazid | Marlex Pharmaceuticals, Inc. | 2025-03-01 |
| 10135-0805-30 | 30 TABLET in 1 BOTTLE, PLASTIC (10135-805-30) | isoniazid | Marlex Pharmaceuticals, Inc. | 2025-03-01 |
| 50090-0410-00 | 100 TABLET in 1 BOTTLE (50090-0410-0) | Isoniazid | A-S Medication Solutions | 2016-06-29 |
| 64950-0216-10 | 100 TABLET in 1 BOTTLE (64950-216-10) | Isoniazid | Genus Lifesciences | 2024-11-01 |
| 64950-0217-03 | 30 TABLET in 1 BOTTLE (64950-217-03) | Isoniazid | Genus Lifesciences | 2024-11-01 |
| 64950-0217-10 | 100 TABLET in 1 BOTTLE (64950-217-10) | Isoniazid | Genus Lifesciences | 2024-11-01 |
| 71335-3083-01 | 30 TABLET in 1 BOTTLE (71335-3083-1) | Isoniazid | Bryant Ranch Prepack | 2026-02-16 |
| 72162-2444-01 | 100 TABLET in 1 BOTTLE (72162-2444-1) | isoniazid | Bryant Ranch Prepack | 2025-02-12 |
| 81665-0107-10 | 100 TABLET in 1 BOTTLE, PLASTIC (81665-107-10) | isoniazid | OMNIVIUM PHARMACEUTICALS LLC. | 2024-10-15 |
| 81665-0108-10 | 100 TABLET in 1 BOTTLE, PLASTIC (81665-108-10) | isoniazid | OMNIVIUM PHARMACEUTICALS LLC. | 2024-10-15 |
| 81665-0108-30 | 30 TABLET in 1 BOTTLE, PLASTIC (81665-108-30) | isoniazid | OMNIVIUM PHARMACEUTICALS LLC. | 2024-10-15 |
| 81665-0108-51 | 1000 TABLET in 1 BOTTLE, PLASTIC (81665-108-51) | isoniazid | OMNIVIUM PHARMACEUTICALS LLC. | 2024-10-15 |
Observed labelers:
OMNIVIUM PHARMACEUTICALS LLC. (4) ·
Genus Lifesciences (3) ·
Marlex Pharmaceuticals, Inc. (3) ·
Teva Pharmaceuticals USA, Inc. (3) ·
Bryant Ranch Prepack (2) ·
A-S Medication Solutions (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.